Non-invasive Brain Surgery Moves a Step Closer
Focused Ultrasound FoundationTen-patient feasibility study shows potential for treating brain disorders with transcranial MR-guided focused ultrasound.
Ten-patient feasibility study shows potential for treating brain disorders with transcranial MR-guided focused ultrasound.
A recently published report in the Journal of Molecular Psychiatry supports the potential of focused ultrasound to treat certain patients with obsessive-compulsive disorder (OCD).
A pre-clinical study published this week in Science Translational Medicine suggests that focused ultrasound may hold a key to providing a non-invasive, non-pharmaceutical approach to treating Alzheimer鈥檚 disease.
The blood-brain barrier has been non-invasively opened in a patient for the first time. A team at Sunnybrook Health Sciences Centre in Toronto used focused ultrasound to enable temporary and targeted opening of the blood-brain barrier (BBB), allowing the more effective delivery of chemotherapy into a patient鈥檚 malignant brain tumor.
Researchers at the University of Virginia (UVA) are starting the first clinical trial in the world using focused ultrasound to treat patients with epilepsy.
Karun Sharma, MD, PhD, Director of Interventional Radiology, and colleagues at Sheikh Zayed Institute for Pediatric Surgical Innovation at Children鈥檚 National Health System in Washington, DC, have completed their clinical trial to treat benign but painful bone tumors (osteoid osteoma) in children.
In a North American first, researchers at Sunnybrook Health Sciences Centre in Toronto have launched a pilot clinical trial to determine the safety, feasibility, and preliminary efficacy of using focused ultrasound to help patients with treatment-resistant major depression.
The results of the first ever clinical trial of focused ultrasound to open the blood-brain barrier (BBB) in patients with Alzheimer鈥檚 disease were published today in Nature Communications and also presented at the Alzheimer鈥檚 Association International Conference (AAIC) in Chicago, Illinois. The pilot trial demonstrated the feasibility and preliminary safety of focally, reversibly and repetitively opening the BBB.
A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound. Researchers and clinicians will highlight breakthrough advances in the use of focused ultrasound in cancer immunotherapy and for opening the blood-brain barrier (BBB).